Sodium-mediated axonal degeneration in inflammatory demyelinating disease.
about
Fatigue in Multiple Sclerosis: Neural Correlates and the Role of Non-Invasive Brain StimulationLongitudinal changes in magnetisation transfer ratio in secondary progressive multiple sclerosis: data from a randomised placebo controlled trial of lamotrigine.Common molecular determinants of tarantula huwentoxin-IV inhibition of Na+ channel voltage sensors in domains II and IVSodium channels and multiple sclerosis: roles in symptom production, damage and therapy.Synthesis and evaluation of a 125I-labeled iminodihydroquinoline-derived tracer for imaging of voltage-gated sodium channels.Loss of Na+ channel beta2 subunits is neuroprotective in a mouse model of multiple sclerosis.Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis.Neuroprotection and repair in multiple sclerosis.Neuroprotection in multiple sclerosis: a therapeutic approach.Relapsing and progressive forms of multiple sclerosis: insights from pathology.Sodium channels in astroglia and microglia.Phenytoin: neuroprotection or neurotoxicity?Persistent alterations in active and passive electrical membrane properties of regenerated nerve fibers of man and mice.Experimental autoimmune encephalomyelitis from a tissue energy perspective.Safinamide and flecainide protect axons and reduce microglial activation in models of multiple sclerosis.Navβ2 knockdown improves cognition in APP/PS1 mice by partially inhibiting seizures and APP amyloid processing.Elevated intracellular Na+ concentrations in developing spinal neurons.Sodium Channel Voltage-Gated Beta 2 Plays a Vital Role in Brain Aging Associated with Synaptic Plasticity and Expression of COX5A and FGF-2.Motor axon excitability during Wallerian degeneration.Histological and ultrastructural analysis of white matter damage after naturally-occurring spinal cord injury.Neuroprotection by safinamide in the 6-hydroxydopamine model of Parkinson's disease.
P2860
Q26773166-B501FCEE-569A-47EA-850E-336D91C572FEQ34014627-DECEB55C-3461-4DE8-BEB0-48EE814C64D8Q35144846-744C329A-9C04-4947-B1E7-EA83743E63EEQ36771880-98D94727-5D72-4B76-8475-CAF5E896EB86Q37150361-0EF33473-0852-4B1F-B6DF-27A9FE5B05C6Q37161778-E831671E-209F-41B5-91B7-1951A83A0577Q37800214-23669A8B-6CFE-4C93-A0CA-F6CC3AF0550FQ38048610-F0FD14B3-6225-48F1-BFB5-554DEF228BA2Q38129748-1D5E60F1-4233-4712-A003-CD72175AE404Q38203770-73566FCB-B2BF-4B9D-A185-3F58A0F20162Q38751614-6AF72D48-3F59-4C6D-8E78-E5155BF98698Q39301693-58F73D6D-0454-411E-BA10-71FE26D90B2AQ40469043-AAF03AB2-FC11-4E48-9DF5-1D7066AF8F4CQ46255661-65F65DD1-66D8-4D01-9602-B8CDE31531C6Q46490485-AE0ABD8A-862A-47DB-A33F-528550B0FFE5Q47147189-85425EB8-379E-4CE0-8F24-D9155149D30FQ48114524-392172F8-0FCB-49B4-AAEE-CCC205812311Q48381635-F758F0DD-E135-49EC-ACB6-0C78A296218DQ48459638-8DA33045-C245-4F45-A509-C864E3AFE2E2Q48499816-60FEB935-406F-4940-A7B6-6420483FFB4DQ53369324-EB5CA0F9-72DD-4639-A2C4-C05DC3608972
P2860
Sodium-mediated axonal degeneration in inflammatory demyelinating disease.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Sodium-mediated axonal degeneration in inflammatory demyelinating disease.
@ast
Sodium-mediated axonal degeneration in inflammatory demyelinating disease.
@en
type
label
Sodium-mediated axonal degeneration in inflammatory demyelinating disease.
@ast
Sodium-mediated axonal degeneration in inflammatory demyelinating disease.
@en
prefLabel
Sodium-mediated axonal degeneration in inflammatory demyelinating disease.
@ast
Sodium-mediated axonal degeneration in inflammatory demyelinating disease.
@en
P1476
Sodium-mediated axonal degeneration in inflammatory demyelinating disease
@en
P2093
David A Bechtold
Kenneth J Smith
P356
10.1016/J.JNS.2005.03.003
P577
2005-06-01T00:00:00Z